CONCISE COMMUNICATIONS Decrease of Cytomegalovirus Replication in Human Immunodeficiency Virus Infected-Patients after Treatment with Highly Active Antiretroviral Therapy

Cytomegalovirus (CMV) viremia, as measured by a hybrid capture assay, was used to measure the effectiveness of “immune reconstitution” in human immunodeficiency virus (HIV)‐infected subjects treated with highly active antiretroviral therapy (HAART). Of the 28 enrolled patients (mean age, 38 years), 86% were male and 68% were antiretrovirally naive. Of the 23 patients who returned for follow-up, baseline median characteristics were 4.1 log10 CMV DNA copies/10 6 white blood cells (WBCs), 5.1 log10 HIV RNA copies/mL, and 35 CD4